Kelly James Patrick, EVP, CFO, and Treasurer of Novavax (NVAX), has demonstrated a clear accumulation bias in his trading activity, with $3.32 million in total buys compared to $1.03 million in sales across 25 transactions. His purchases have been concentrated in NVAX, with no trades in other companies. Notably, Patrick executed two large acquisitions totaling $1.76 million and $1.53 million on March 2, 2026, and March 3, 2025, respectively, alongside smaller periodic purchases. These were supplemented by multiple smaller transactions, including a $287,631 purchase on March 1, 2026, and a $236,047 acquisition on March 1, 2025.
While his selling activity has been minimal, the most notable sale occurred on August 16, 2024, when he disposed of $30,676 worth of shares—a fraction of his buy volume. The absence of recent trades suggests a holding pattern since March 2026. Patrick’s transactions, particularly the multimillion-dollar acquisitions in early 2025 and 2026, indicate a sustained commitment to NVAX, with sales playing only a minor role in his overall trading history. The lack of diversification outside NVAX further underscores his concentrated position in the company.
AI-assisted summary